助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   chinese patent medicine 在 肿瘤学 分类中 的翻译结果: 查询用时:0.012秒
图标索引 在分类学科中查询
所有学科
肿瘤学
中药学
中医学
有机化工
中西医结合
无机化工
工业经济
药学
环境科学与资源利用
更多类别查询

图标索引 历史查询
 

chinese patent medicine
相关语句
  中成药
    The Chinese Patent Medicine Fei DanSeries Treating 290 Patients with Cancer ofLung
    “肺丹”系列中成药治疗肺癌290例
短句来源
  “chinese patent medicine”译为未确定词的双语例句
    OBJECTIVE:To investigate the relationship between the SDS in TCM and the biological behavior of patients with gastric carcinoma and the effect of Shenqi Fuzheng Injection(SI),a kind of Chinese patent medicine strengthening the spleen and replenishing qi,on it.
    目的:研究中医脾虚症与胃癌患者临床生物学行为之间的关系,以及健脾益气中药参芪扶正注射液对其影响。
短句来源
查询“chinese patent medicine”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  chinese patent medicine
Therapeutic effect evaluation of acupuncture and chinese patent medicine on rheumatoid arthritis
      


45 cases of chronic gastritis diagnosed by fibrogastroscopy and histology were treated with Weichangkang capsule. The total effective rate of the drug amounted to 91.1%. The differences in therapeutic effects on various types of gastritis were of no statistical significance. Therefore, Weichangkang capsule has proved effective in treating all the 3 types of chronic gastritis. In animal experiments it was found that Weichangkang could enhance gastrointestinal motility and had a protective effect on the gastric...

45 cases of chronic gastritis diagnosed by fibrogastroscopy and histology were treated with Weichangkang capsule. The total effective rate of the drug amounted to 91.1%. The differences in therapeutic effects on various types of gastritis were of no statistical significance. Therefore, Weichangkang capsule has proved effective in treating all the 3 types of chronic gastritis. In animal experiments it was found that Weichangkang could enhance gastrointestinal motility and had a protective effect on the gastric mucosa of rats. The mechanism of action of this drug lies in that it can protect gastric mucosa by increasing secretion of the gastric juice and mucoid gel without producing any side effects. Therefore, it may be suggested that Weichangkang is a new type of Chinese patent medicine in the treatment of chronic gastritis.

对45例经纤维胃镜及病理活检证实为慢性胃炎,用胃肠康胶囊治疗的患者,进行了系统的临床观察及治疗后的胃镜复查,结果临床总有效率为91.1%;对不同证型其疗效差异无显著性意义,故可用于多种证型。其机理是增加胃液分泌量和粘液凝胶的防护层,以阻止“攻击因子”对胃粘膜的损伤。

Aim: To observe the treatment effect of Capsule Cidan. one of Chinese patent medicine, during chemotherapy and radiotherapy of liver cancer. Method: Divided 54 cases of primary liver cancer patients which can't excise with operation decided with exploratory laparotomy into two group: A group contain 29 cases, B group contain 25 cases. A group with artery chemotherapy, radiotherapy and Capsule Cidan, whereas B group with only artery chemotherapy and radiotherapy. Result: The palliate rate of hepatalgia,...

Aim: To observe the treatment effect of Capsule Cidan. one of Chinese patent medicine, during chemotherapy and radiotherapy of liver cancer. Method: Divided 54 cases of primary liver cancer patients which can't excise with operation decided with exploratory laparotomy into two group: A group contain 29 cases, B group contain 25 cases. A group with artery chemotherapy, radiotherapy and Capsule Cidan, whereas B group with only artery chemotherapy and radiotherapy. Result: The palliate rate of hepatalgia, windy and short-term effective rate, survival rate of one year of A group were 92% , 89. 3% , 72. 4% and 93. 1 % , respectively, and they were higher than that of B group, the P value were lower than 0. 05. Conclusion: Capsule Cidan can combine with rediotherapy and chemotherapy to improve its therapeutic effect.

目的:观察中成药慈丹胶囊在肝癌化疗、放疗中的作用。方法:将54例经剖腹探查判定不可手术切除Ⅱ期的原发性肝癌分为两组,其中动脉化疗+放疗+慈丹胶囊组29例(治疗A组),仅动脉化疗+放疗组25例(对照B组)。结果:治疗组肝区疼痛减轻率、腹胀减轻率、近期有效率、1年生存率分别为92%、89.3%、72.4%、93.1%,分别高于对照组,P均<0.05。结论:慈丹胶囊与放疗、化疗并用,可望提高其疗效。

BACKGROUND:According to the theory of traditional Chinese medicine(TCM),spleen deficiency syndrome(SDS) can reflect the essence of a disease.Modern medical experimental and clinical researches have shown that SDS is closely related to the occurrence and development of gastric carcinoma. OBJECTIVE:To investigate the relationship between the SDS in TCM and the biological behavior of patients with gastric carcinoma and the effect of Shenqi Fuzheng Injection(SI),a kind of Chinese patent medicine...

BACKGROUND:According to the theory of traditional Chinese medicine(TCM),spleen deficiency syndrome(SDS) can reflect the essence of a disease.Modern medical experimental and clinical researches have shown that SDS is closely related to the occurrence and development of gastric carcinoma. OBJECTIVE:To investigate the relationship between the SDS in TCM and the biological behavior of patients with gastric carcinoma and the effect of Shenqi Fuzheng Injection(SI),a kind of Chinese patent medicine strengthening the spleen and replenishing qi,on it. DESIGN:A case-controlled study based on the diagnosis. SETTING:The Third Department of Surgery and Department of Obstetrics and Gynecology,the Fourth Hospital of Hebei Medical University. PARTICIPANTS:Totally 102 patients were selected from 450 patients who suffered from advanced gastric carcinoma and were hospitalized in the Department of Surgery of our hospital to receive an operation from October 2000 to May 2002,of which 59 patients were male and 43 patients were female,aged from 31 to 74 years old,with a mean age of 55.6 years old.According to syndrome differentiation of TCM,102 patients with gastric carcinoma were evaluated before operation and divided into two groups,the non-SDS group and the SDS group;and the SDS group were subdivided into the operation group and operation+SI group. METHODS:All patients received an operation.On the first day after operation,Chinese herbal medicine SI(manufactured by Guangdong Limin Pharmaceutical Factory,and with Radix Codonopsis Pilosulae and Radix Astragali seu Hedysari as its main components) was intravenously given to the patients in the operation+SI group,250 mL daily for eight days.On the ninth day after the operation,2 mL venous blood was drawn anticoagulatively for assaying relevant immunologic indexes. MAIN OUTCOME MEASURES:Infiltration depth and differentiation degree of the cancerous cells,metastasis of lymphnode,TNM stage,etc.were statistically analyzed.The red blood cell C3b receptor rosette(RBC-C3bRR),the red blood cell immune complex rosette(RBC-ICR),the argentaffin protein content of T-lymphocyte Ag-NORs and NK cell activity were determined. RESULTS:Sixty-three of the 102 patients were complicated by SDS(61.8%).There were significant differences between the non-SDS group and the SDS group in the depth of infiltration(deeper in the SDS group),metastasis of lymphnode(severer in the SDS group),cell differentiation(lower in the SDS group) and TNM stage(later in the SDS group)(P< 0.05).Compared with those in the simple operation group,the RBC-C3bRR,T lymphocytes Ag-NORs,NK cell activity were significantly increased and the RBC-ICR were significantly decreased in the operation+SI group(P< 0.05). CONCLUSION:There is a close relation between the SDS and the clinical biological behaviors of patients with gastric carcinoma.The prognosis of patients complicated by SDS is worse,and SI may effectively improve the immunological function of the patients.

背景:中医学理论认为脾虚症能反映疾病的本质,现代医学实验和临床研究表明中医脾虚症与胃癌的发生发展有着密切的关系。目的:研究中医脾虚症与胃癌患者临床生物学行为之间的关系,以及健脾益气中药参芪扶正注射液对其影响。设计:以诊断为依据的病例对照研究。单位:河北医科大学第四医院外三科、妇产科。对象:选择2000-10/2002-05在本院外科住院进行手术治疗的进展期胃癌患者102例(同期该类患者450例),男59例,女43例;年龄31~74岁,平均55.6岁。根据中医辨证标准,将102例患者分为胃癌无脾虚症和有脾虚症两组,并将有脾虚症组患者分为单纯手术组与手术+健脾治疗组。方法:所有患者均行手术治疗,手术+健脾治疗组在手术后第1天开始,静脉滴注健脾益气中药参芪扶正注射液250mL(广东省利民制药厂生产,主要成分:党参、黄芪),1次/d,共8d。术后第9天静脉抽抗凝血2mL用于相关免疫指标测定。主要观察指标:分析统计胃癌浸润深度、分化程度、淋巴结转移以及TNM分期等。检测红细胞C3b受体花环(RBC-C3bRR)、免疫复合物花环(RBC-ICR)、T淋巴细胞嗜银蛋白含量以及NK细胞活性。结果:102例胃癌患者中有63例(...

背景:中医学理论认为脾虚症能反映疾病的本质,现代医学实验和临床研究表明中医脾虚症与胃癌的发生发展有着密切的关系。目的:研究中医脾虚症与胃癌患者临床生物学行为之间的关系,以及健脾益气中药参芪扶正注射液对其影响。设计:以诊断为依据的病例对照研究。单位:河北医科大学第四医院外三科、妇产科。对象:选择2000-10/2002-05在本院外科住院进行手术治疗的进展期胃癌患者102例(同期该类患者450例),男59例,女43例;年龄31~74岁,平均55.6岁。根据中医辨证标准,将102例患者分为胃癌无脾虚症和有脾虚症两组,并将有脾虚症组患者分为单纯手术组与手术+健脾治疗组。方法:所有患者均行手术治疗,手术+健脾治疗组在手术后第1天开始,静脉滴注健脾益气中药参芪扶正注射液250mL(广东省利民制药厂生产,主要成分:党参、黄芪),1次/d,共8d。术后第9天静脉抽抗凝血2mL用于相关免疫指标测定。主要观察指标:分析统计胃癌浸润深度、分化程度、淋巴结转移以及TNM分期等。检测红细胞C3b受体花环(RBC-C3bRR)、免疫复合物花环(RBC-ICR)、T淋巴细胞嗜银蛋白含量以及NK细胞活性。结果:102例胃癌患者中有63例(61.8%)合并不同程度的脾虚症。有脾虚症组与无脾虚症组患者相比,其肿瘤浸润深度、分化程度、淋巴结转移以及TNM分期的构成?

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关chinese patent medicine的内容
在知识搜索中查有关chinese patent medicine的内容
在数字搜索中查有关chinese patent medicine的内容
在概念知识元中查有关chinese patent medicine的内容
在学术趋势中查有关chinese patent medicine的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社